(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(o-tolyl)propanoic acid, 98%, 1g

{[5-(4-Fluorophenyl)isoxazol-3-yl]methyl}amine hydrochloride, 95.0%, 2.5g

C-(1,3-Dimethyl-pyrrolidin-3-yl)-methylamine, 95.0%, 1g

(2s,4r)-4-Fluoropyrrolidine-2-carboxamide hydrochloride, 95+%, 250mg

4-(1H-Pyrazol-3-yl)benzonitrile, 97.0%, 5g

Fmoc-2-Nal-OH>98.0%(HPLC)(T)5g

Morpholin-2-ylmethanol hydrochloride, 95.0%, 10g

(1S)-2′-[[(1-Methylethyl)amino]carbonyl][1,1′-binaphthalene]-2-carboxylic acid, 100mg

3-Bromo-4-chlorothieno[3,2-c]pyridine, 95.0%, 250mg

n-(3-Chlorophenyl)pyrrolidin-3-amine, 95%, 500mg

[(4-fluorophenyl)(phenyl)methyl](methyl)amine, 95%, 1g

4,4-Difluoro-1,3-dimethyl-4-bora-3a,4a-diaza-s-indacene>98.0%(GC)1g

3-((tert-Butoxycarbonyl)amino)-3-(4-cyanophenyl)propanoic acid, 97%, 1g